𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Malignant reversion of a human osteosarcoma cell line, Saos-2, by inhibition of NFκB

✍ Scribed by Valentine B Andela; Tzong-Jen Sheu; Edward J Puzas; Edward M Schwarz; Regis J O'Keefe; Randy N Rosier

Book ID
117052532
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
183 KB
Volume
297
Category
Article
ISSN
0006-291X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biliverdin inhibits activation of NF-κB:
Biliverdin inhibits activation of NF-κB: Reversal of inhibition by human biliverdin reductase
✍ Peter E.M. Gibbs; Mahin D. Maines 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 417 KB

## Abstract hBVR functions in the cell as a reductase and as a kinase. In the first capacity, it reduces biliverdin, the product of HO activity, to the effective intracellular antioxidant, bilirubin; as a dual‐specificity kinase (S/T/Y) it activates the MAPK and IGF/IRK receptor signal transduction

Antisense inhibition of urokinase: Effec
Antisense inhibition of urokinase: Effect on malignancy in a human osteosarcoma cell line
✍ Carsten Haeckel; Sabine Krueger; Albert Roessner 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 251 KB 👁 2 views

Expression of urokinase-type plasminogen activator (u-PA) strongly correlates with a malignant tumor cell phenotype. In the multistep process of metastasis, different cellular functions are influenced by urokinase. The enzyme is known to be effective via both proteolytical and signal transduction me